The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
Open accessAbstract
We performed whole-exome and whole-genome sequencing in 927 late-onset Alzheimer disease (LOAD) cases, 852 early-onset AD (EOAD) cases, and 1273 controls from France. We assessed the evidence for gene-based association of rare variants with AD in 6 genes for which an association with such variants was previously claimed. When aggregating protein-truncating and missense-predicted damaging variants, we found exome-wide significant association between EOAD risk and rare variants in SORL1, TREM2, and ABCA7. No exome-wide significant signal was obtained in the LOAD sample, and significance of the order of 10-6 was observed in the whole AD group for TREM2. Our study confirms previous gene-level results for TREM2, SORL1, and ABCA7 and provides a clearer insight into the classes of rare variants involved. Despite different effect sizes and varying cumulative minor allele frequencies, the rare protein-truncating and missense-predicted damaging variants in TREM2, SORL1, and ABCA7 contribute similarly to the heritability of EOAD and explain between 1.1% and 1.5% of EOAD heritability each, compared with 9.12% for APOE ε4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“both SORL1 and ABCA7 genes—already detected by GWAS—carried numerous loss-of-function variants leading to strong increases in AD risk [9, 98, 128].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SORL1 is now considered as a major AD risk factor gene, because of increased frequencies of rare coding variant carriers in cases as compared to cognitively-healthy controls [2, 22–24].”
From Impaired SorLA maturation and trafficking as a new mechanism for SORL1 missense variants in Alzheimer disease (2021) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Exome and genome sequencing recently allowed the identification of three genes harboring a higher burden of rare non-synonymous variants in AD cases as compared to controls: TREM2, SORL1, and ABCA7 [2].”
From Impaired SorLA maturation and trafficking as a new mechanism for SORL1 missense variants in Alzheimer disease (2021) · cites this paper as [2]
In the citing paper
“we also identified ten genes located in our genome-wide loci as having rare deleterious coding, splicing or LOF burden associations with LOAD (false discovery rate (FDR) P < 0.01), including previously implicated rare-variant signals in ABCA7, TREM2, and SORL1 (refs. 14,49–55), and additional associations with TREML4 in the TREM2 locus, TAP2 and PSMB8 in the HLA-DRB1 locus, PIP in the EPHA1 locus,”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Cited by
Sorted by citations
Items 101–166 of 166
Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease
Zhou, X., Cao, H., Jiang, Y., Chen, Y., Zhong, H., Fu, W. Y., Lo, R. M. N., Wong, B. W. Y., Cheng, E. Y. L., Mok, K. Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14214 · Cited by 9
Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives
Hroudová, J., & Fišar, Z. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111491 · Cited by 9
Li, M., Mo, Y., Yu, Q., Anayyat, U., Yang, H., Zhang, F., Wei, Y., & Wang, X. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115029 · Cited by 10
Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders
Ayer, A. H., Wojta, K. J., Ramos, E. M., Dokuru, D. R., Chen, J., Karydas, A. M., Papatriantafyllou, J. D., Agiomyrgiannakis, D., Kamtsadeli, V., Tsinia, N., et al. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000339 · Cited by 10
Tarozzi, M. E., Bartoletti‐Stella, A., Dall’Olio, D., Matteuzzi, T., Baiardi, S., Parchi, P., Castellani, G., & Capellari, S. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01173-4 · Cited by 12
Association between apolipoprotein E ε4 status and the risk of Alzheimer’s disease: a meta-analysis
Ren, Z., Guan, Z., Guan, Q., Guan, H., & Che, H. (2025) · BMC Neuroscience · doi:10.1186/s12868-024-00914-8 · Cited by 8
Lessons from genetic studies in Alzheimer disease
Nicolas, G. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2023.12.006 · Cited by 9
Self-citationBenefits and Challenges of Rare Genetic Variation in Alzheimer’s Disease
Grozeva, D., Saad, S., Menzies, G. E., & Sims, R. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0161-5 · Cited by 8
Evaluation of the Clinical Features Accompanied by the Gene Mutations
Eryılmaz, I. E., Bakar, M., Egelí, Ü., Çeçener, G., Yurdacan, B., Çolak, D. K., & Tunca, B. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000437 · Cited by 7
Decoding Cell Death: From a Veritable Library of Babel toVade Mecum?
Hughes, L. D., Wang, Y., Meli, A. P., Rothlin, C. V., & Ghosh, S. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102819-072601 · Cited by 8
What contribution can genetics make to predict the risk of Alzheimer's disease?
Schramm, C., Wallon, D., Nicolas, G., & Charbonnier, C. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.005 · Cited by 8
Self-citationMathioudakis, L., Dimovasili, C., Bourbouli, M., Latsoudis, H., Kokosali, E., Gouna, G., Vogiatzi, E., Basta, M., Kapetanaki, S., Panagiotakis, S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.002 · Cited by 7
Gawęda-Walerych, K., Sitek, E. J., Borczyk, M., Narożańska, E., Brockhuis, B., Korostyński, M., Schinwelski, M. J., Siemiński, M., Sławek, J. W., & Żekanowski, C. (2022) · Genes · doi:10.3390/genes13122361 · Cited by 7
Mušálková, D., Přistoupilová, A., Jedličková, I., Hartmannová, H., Trešlová, H., Nosková, L., Hodaňová, K., Bittmanová, P., Stránecký, V., Jiřička, V., et al. (2024) · Genes Brain & Behavior · doi:10.1111/gbb.12882 · Cited by 5
Karsak, M., Glebov, K., Scheffold, M., Bajaj, T., Kawalia, A., Karaca, I., Rading, S., Kornhuber, J., Peters, O., Díez-Fairén, M., et al. (2019) · Human Mutation · doi:10.1002/humu.23904 · Cited by 6
Microglial MS4A4A Protects against Epileptic Seizures in Alzheimer's Disease
Jiang, M., Li, Q., Chen, J., Li, R., Yao, J., Hu, Y., Zhang, H., Cai, L., Luo, M., Sun, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202417733 · Cited by 6
TREM2 coding variants in Slovak Alzheimer's disease patients
Ďurmanová, V., Javor, J., Párnická, Z., Minárik, G., Ocenasova, A., Vašečková, B., Kiralyova, I., Šutovský, S., Petrovič, R., & Shawkatová, I. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2104105 · Cited by 5
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer’s disease
Andersen, O. M., de Waal, M. W. J., Monti, G., Tesi, N., Jensen, A. M. G., de Geus, C. M., van Spaendonk, R. M. L., Vogel, M. J., Ahmad, S., Amin, N., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00907-z · Cited by 15
Self-citationPharmacological Benefits of Cinnamaldehyde: A Comprehensive Insight
Ali, A., Ismayel, S. M., Samama, M., Kumar, A., & Gupta, P. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072322707240902074426 · Cited by 4
Abu‐Amara, H., Zhao, W., Li, Z., Leung, Y. Y., Schellenberg, G. D., Wang, L., Moorjani, P., Dey, A. B., Dey, S., Zhou, X., et al. (2025) · Genes · doi:10.3390/genes16060640 · Cited by 5
Górska, A. M., Santos‐García, I., Kvasnička, A., Dobešová, D., Friedecký, D., Gildenblat, J., & Pahnke, J. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102891 · Cited by 6
Input of exome sequencing in early‐onset cerebral amyloid angiopathy
Grangeon, L., Charbonnier, C., Rousseau, S., Richard, A. C., Quenez, O., Zaréa, A., Boland, A., Olaso, R., Deleuze, J., CAA study group, et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70027 · Cited by 4
Self-citationLuikku, A. J., Nerg, O., Koivisto, A. M., Hänninen, T., Junkkari, A., Kemppainen, S., Juopperi, S.-P., Sinisalo, R., Pesola, A., Soininen, H., et al. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae083 · Cited by 4
Ge, S., Cai, M., & Pei, G. (2022) · Cell Discovery · doi:10.1038/s41421-022-00444-9 · Cited by 3
The Future of Cognitive Screening in Neurodegenerative Diseases
Umfleet, L. G., Bilder, R. M., Loring, D. W., Thames, A. D., Hampstead, B. M., Bauer, R. M., Drane, D. L., & Cavanagh, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221077 · Cited by 3
Miguel, L., Gervais, J., Nicolas, G., & Lecourtois, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230211 · Cited by 4
Self-citationKhalili-Moghadam, F., Nejad, J. H., Badri, T., Sadeghi, M., & Gharechahi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37556 · Cited by 3
A novel SORL1 mutation in a pedigree affected by early-onset Alzheimer's disease
Redaelli, V., Ricci, M., Sole, A. D., Piccione, M. M., Prioni, S., & Rossi, G. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241296017 · Cited by 3
Wang, M., Sun, L., Xu, X., Dai, R., Tan, Q., Zhu, Y., Xu, A., Zheng, W., Tu, Y., Zhou, D., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf063 · Cited by 3
Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
Coppola, C., Saracino, D., Oliva, M., Cipriano, L., Puoti, G., Pappatà, S., Fede, G. D., Catania, M., Ricci, M., Cimini, S., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04774-y · Cited by 3
Castelot, R., Zaréa, A., Wallon, D., Rovelet‐Lecrux, A., Schramm, C., Quillard‐Muraine, M., Beaume, A., Blanc, F., Bousiges, O., Dumurgier, J., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01748-0 · Cited by 2
Self-citationChen, J., Zhang, X., Chen, X., Yu, W., Jia, M., Zhu, L., Liu, Z., & Hu, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099591 · Cited by 2
Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome
Saternos, H., Hamlett, E. D., Guzman, S. J., Head, E., Granholm, A., & Ledreux, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240043 · Cited by 2
Cochran, J. N., McKinley, E., Cochran, M., Amaral, M. D., Moyers, B. A., Lasseigne, B. N., Gray, D. E., Lawlor, J. M. J., Prokop, J. W., Geier, E. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/748046 · Cited by 2
Yan, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735170868.793558625 · Cited by 2
The Psychopathology and Neuropsychology of Alzheimer’s Disease: A New Narrative
Barakat, M., Annan, I., Sader, A., & Khoury, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_54-1 · Cited by 1
Lipid transport mechanisms in human ABCA family transporters: a structural perspective
Dolai, S., & Alam, A. (2026) · Biochemical Society Transactions · doi:10.1042/bst20250138 · Cited by 1
The Alzheimer's disease risk gene SORL1 is a regulator of excitatory neuronal function
Williams, C. A., Rose, S. E., Stamenković, V., Reid, A. N., Travaglini, K. J., Smith, S. E. P., & Young, J. E. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71862 · Cited by 1
Huq, A. J., Thompson, B. A., & Winship, I. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2388765 · Cited by 1
Achouri-Rassas, A., Fray, S., Saied, Z., Sassi, S. B., Ali, N., & Baraket, G. (2025) · Neurological Research · doi:10.1080/01616412.2025.2472841 · Cited by 1
Identification of Novel Gene variants in Patients with Alzheimer’s Disease by Whole Exome Sequencing
Xiaodong, P., Murong, Y., Jingjing, X., Pan, Q., Menghao, Y., Jing, X., Lang, C., Ruijie, L., Qinlin, L., Chen, Z., et al. (2020) · Annals of Alzheimer s and Dementia Care · doi:10.17352/aadc.000009 · Cited by 1
Schramm, C., Charbonnier, C., Zaréa, A., Lacour, M., Wallon, D., collaborators, C., Boland, A., Deleuze, J.-F., Olaso, R., Alarcon, F., et al. (2021) · doi:10.1101/2021.06.30.450554 · Cited by 1
Self-citationGenetic Risk Factors for Complex Forms of Alzheimer’s Disease
Bellenguez, C., & Lambert, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_4
Self-citationПроблемы при реализации креативного менеджмента в организации
Цыганкова, В. Н. (2010) · Креативная экономика
Génétique de la maladie d’Alzheimer et des maladies apparentées : qu’en sait-on en 2022 ?
Formaglio, M., Ber, I. L., & Wallon, D. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.017 · Cited by 2
Self-citationEvans, K., & Gospodinova, K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732773136.793567595
Maladie d’Alzheimer et affections apparentées
Auriacombe, S. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-76331-1.00011-2
Self-citationGenetica della malattia di Alzheimer
Wallon, D., & Nicolas, G. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)47093-0
Self-citationAnalysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
Chaves, J. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248279
Prodrugs for neurodegenerative diseases
Guglielmi, P., Granese, A., Secci, D., & Chimenti, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15635-9.00011-0
Pathophysiology and Underlying Mechanisms: Pathways to Alzheimer’s Plaque Formation
Roychowdhury, P., Gobinath, M., Dutta, S., Swain, S. S., Khan, I., De, A., Karri, V. V. S. R., & Kuppusamy, G. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_4 · Cited by 2
The Psychopathology and Neuropsychology of Alzheimer’s Disease: A New Narrative
Barakat, M., Annan, I., Sader, A., & Khoury, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_54
Additional file 1 of Probability of Alzheimer’s disease based on common and rare genetic variants
Escott‐Price, V., & Schmidt, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15184680
Schramm, C., Charbonnier, C., Zaréa, A., Lacour, M., Wallon, D., Boland, A., Deleuze, J., Olaso, R., Alarcon, F., Campion, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20168234
Self-citationTarozzi, M., Bartoletti‐Stella, A., Dall’Olio, D., Matteuzzi, T., Baiardi, S., Parchi, P., Castellani, G., & Capellari, S. (2022) · Figshare · doi:10.6084/m9.figshare.19159108
Cuppens, T. (2019) · theses.fr (ABES) · doi:10.70675/e4540409z738dz4ae0z8e45zb9737a13730a
Dautricourt, S. (2021) · theses.fr (ABES) · doi:10.70675/63472a25z31eaz4ebczaebdzd8d2e061b4b8
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
Bitar, F. E., Dawsari, G. A., Qadi, N., Rajeh, S. A., Abouelhoda, M., Alsubaie, S., Majrashi, N., Magrashi, A. I., Amari, H. A. A., Alghamdi, F., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1765569
Venkei, Z. G., & Savelieff, M. G. (2026) · Exploration of neuroscience · doi:10.37349/en.2026.1006139
SuperAging is not the inverse of common-variant Alzheimer’s risk: evidence across genetic ancestries
Piras, I. S., Capuano, A. W., Maher, A. C., Schafer, R., Bonfitto, A., Song, S., Taguinod, F., Goldstein, F. C., Roberts, A., Okonkwo, O. C., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02124-2
Laureyssen, C., Thal, D. R., & Sleegers, K. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03085-4
Targeting the peripheral immune system for treatment of Alzheimer’s disease
Almasarani, E., Fog, M. H., Vorup‐Jensen, T., & Juul‐Madsen, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00054-9
Metadata
- Authors
- Bellenguez, C., Charbonnier, C., Grenier-Boley, B., Quenez, O., Le Guennec, K., Nicolas, G., Chauhan, G., Wallon, D., Rousseau, S., Richard, A. C., Boland, A., Bourque, G., Munter, H. M., Olaso, R., Meyer, V., Rollin-Sillaire, A., Pasquier, F., Letenneur, L., Redon, R., Dartigues, J.-F., Tzourio, C., Frebourg, T., Lathrop, M., Deleuze, J.-F., Hannequin, D., Genin, E., Amouyel, P., Debette, S., Lambert, J.-C., Campion, D., Hannequin, D., Campion, D., Wallon, D., Martinaud, O., Zarea, A., Nicolas, G., Rollin-Sillaire, A., Bombois, S., Mackowiak, M.-A., Deramecourt, V., Pasquier, F., Michon, A., Le Ber, I., Dubois, B., Godefroy, O., Etcharry-Bouyx, F., Chauviré, V., Chamard, L., Berger, E., Magnin, E., Dartigues, J.-F., Auriacombe, S., Tison, F., Sayette, V. D. L., Castan, D., Dionet, E., Sellal, F., Rouaud, O., Thauvin, C., Moreaud, O., Sauvée, M., Formaglio, M., Mollion, H., Roullet-Solignac, I., Vighetto, A., Croisile, B., Didic, M., Félician, O., Koric, L., Ceccaldi, M., Gabelle, A., Marelli, C., Labauge, P., Jonveaux, T., Vercelletto, M., Boutoleau-Bretonnière, C., Castelnovo, G., Paquet, C., Dumurgier, J., Hugon, J., De Boisgueheneuc, F., Belliard, S., Bakchine, S., Sarazin, M., Barrellon, M.-O., Laurent, B., Blanc, F., Pariente, J., & Jurici, S.
- Affiliations
- Inserm (FR)
- Université de Bordeaux (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- McGill University and Génome Québec Innovation Centre (CA)
- Centre National de la Recherche Scientifique (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Centre National de Recherche en Génomique Humaine (FR)
- Centre Hospitalier du Rouvray (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- ORCID
- Bellenguez, Céline
- Charbonnier, Camille
- Quenez, Olivier
- Chauhan, Ganesh
- Boland, Anne
- Bourque, Guillaume
- Olaso, Robert
- Meyer, Vincent
- Letenneur, Luc
- Redon, Richard
- Tzourio, Christophe
- Lathrop, Mark
- Deleuze, Jean-François
- Amouyel, Philippe
- Debette, Stéphanie
- Lambert, Jean-Charles
- Bombois, Stéphanie
- Deramecourt, Vincent
- Dubois, Bruno
- Godefroy, Olivier
- Tison, François
- Sayette, Vincent de la
- Rouaud, Olivier
- Moreaud, Olivier
- Sauvée, Mathilde
- Croisile, Bernard
- Didic, Mira
- Félician, Olivier
- Koric, Lejla
- Ceccaldi, Mathieu
- Gabelle, Audrey
- Labauge, Pierre
- Jonveaux, Thérèse
- Castelnovo, Giovanni
- Paquet, Claire
- Dumurgier, Julien
- Hugon, Jacques
- Belliard, Serge
- Sarazin, Marie
- Laurent, Bernard
- Blanc, Frédéric
- Pariente, Jérémie
- Jurici, Snejana
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 59
- Pages
- 220.e1-220.e9
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2735794637
- Cited by
- 166
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 14 · 2022: 29 · 2021: 24 · 2020: 13 · 2019: 28 · 2018: 16
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- Funders
- France Génomique National infrastructure
- Centre National de Génotypage
- National Foundation for Alzheimer's disease and related disorders
- Institut Pasteur de Lille
- Inserm
- FRC
- Lille Métropole Communauté Urbaine council
- French government's LABEX
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, rare variants, TREM2, SORL1, ABCA7, early-onset Alzheimer's disease, late-onset Alzheimer's disease, truncating mutations, missense mutations, genetic risk, heritability, APOE ε4, gene-based association
- MeSH terms
- Whole Genome Sequencing, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Receptors, Immunologic, Genetic Variation, ATP-Binding Cassette Transporters, Genetic Predisposition to Disease, LDL-Receptor Related Proteins, Membrane Transport Proteins, Apolipoprotein E4, Genome-Wide Association Study, Young Adult, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
